Pear Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 80
Employees
  • Latest Deal Type
  • Mezzanine
  • Investors
  • 12

Pear Therapeutics General Information

Description

Developer of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians and cost-effective services for payors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Outcome Management (Healthcare)
Application Software
Primary Office
  • 200 State Street
  • 13th Floor
  • Boston, MA 02109
  • United States

Pear Therapeutics Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Mezzanine 07-Jul-2020 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 04-Jan-2019 0000 00000 00000 Completed Generating Revenue
5. Early Stage VC (Series B) 28-Dec-2017 0000 0000 00000 Completed Generating Revenue
4. Grant 01-Jan-2017 00000 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 26-Jan-2016 0000 0000 000.00 Completed Generating Revenue
2. Accelerator/Incubator $5M Completed Generating Revenue
1. Seed Round 19-Mar-2015 $5M $5M 0000 Completed Generating Revenue
To view Pear Therapeutics’s complete valuation and funding history, request access »

Pear Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series A 24,002,981 $0.000100 8% $0.92 $0.92 1x $0.92 34.95%
To view Pear Therapeutics’s complete cap table history, request access »

Pear Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharma
Other Healthcare Technology Systems
Boston, MA
80 As of 2018
00000
000000000000 00000

00000000

u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
0000000000 0000000 (0000000000)
Montreal, Canada
00 As of 0000
00.000
000000000 00.000

00000000

olore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui of
00000000000 00000000
Boca Raton, FL
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pear Therapeutics Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jintronix Venture Capital-Backed Montreal, Canada 00 00.000 000000000 00.000
00000000000 000000 Private Equity-Backed Boca Raton, FL 000 00000 0000000 0000 00000
00000000 Venture Capital-Backed Santa Barbara, CA 0 00.000 0000000000 0 00.000
00000 000000 Venture Capital-Backed San Francisco, CA 000 00000 000000000 - 00000
00000000 000000 Private Equity-Backed Minneapolis, MN 000 00000 000000000000 00000
You’re viewing 5 of 35 competitors. Get the full list »

Pear Therapeutics Executive Team (16)

Name Title Board Seat Contact Info
Corey McCann Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Christopher Guiffre JD Chief Operating Officer & Chief Financial Officer
Alex Waldron Chief Strategy Officer
Julia Strandberg Chief Commercial Officer
Kathy Jeffery Chief People Officer
You’re viewing 5 of 16 executive team members. Get the full list »

Pear Therapeutics Board Members (13)

Name Representing Role Since
Andrew Schwab 5AM Ventures Board Member 000 0000
Corey McCann Ph.D Pear Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Delaine Cheong Temasek Holdings Board Observer 000 0000
Hu Hongjie Temasek Holdings Board Member 000 0000
Jamil Beg 5AM Ventures Board Observer 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Pear Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pear Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Blue Water Life Science Fund Hedge Fund Minority 000 0000 000000 0
TrustBridge Partners Growth/Expansion Minority 000 0000 000000 0
EDBI Venture Capital Minority 000 0000 000000 0
Novartis Corporation Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Pear Therapeutics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 07-Jan-2020 000000000 00000 00 Buildings and Property 00000 000000 00.0
To view Pear Therapeutics’s complete investments history, request access »